Intranasal GDNF for Parkinson's Disease: Next steps in preclinical development

被引：0
|
作者：
Waszczak, Barbara Lee [1 ]
Wachtman, Lynn [2 ]
Newsome, Ginnifer C. [2 ]
Aly, Amirah [1 ]
Silva, Nilsa [2 ]
Westmoreland, Susan [2 ]
Rowlett, James [2 ]
Migliore, Mattia M. [3 ]
机构：
[1] Northeastern Univ, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA
[3] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
来源：
FASEB JOURNAL | 2013年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1177.10
引用
收藏
页数：1
相关论文
共 50 条
  • [1] NEUROTROPHIC AND NEUROPROTECTIVE EFFICACY OF INTRANASAL GDNF IN A RAT MODEL OF PARKINSON'S DISEASE
    Migliore, M. M.
    Ortiz, R.
    Dye, S.
    Campbell, R. B.
    Amiji, M. M.
    Waszczak, B. L.
    NEUROSCIENCE, 2014, 274 : 11 - 23
  • [2] Visualizing the next steps in Parkinson disease
    Bodis-Wollner, I
    ARCHIVES OF NEUROLOGY, 2002, 59 (08) : 1233 - 1234
  • [3] GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop
    Barker, Roger A.
    Bjorklund, Anders
    Gash, Don M.
    Whone, Alan
    Laar, Amber Van
    Kordower, Jeffrey H.
    Bankiewicz, Krystof
    Kieburtz, Karl
    Saarma, Mart
    Booms, Sigrid
    Huttunen, Henri J.
    Kells, Adrian P.
    Fiandaca, Massimo S.
    Stoessl, A. Jon
    Eidelberg, David
    Federoff, Howard
    Voutilainen, Merja H.
    Dexter, David T.
    Eberling, Jamie
    Brundin, Patrik
    Isaacs, Lyndsey
    Mursaleen, Leah
    Bresolin, Eros
    Carroll, Camille
    Coles, Alasdair
    Fiske, Brian
    Matthews, Helen
    Lungu, Codrin
    Wyse, Richard K.
    Stott, Simon
    Lang, Anthony E.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (03) : 875 - 891
  • [4] Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson's Disease
    Hernando, Sara
    Herran, Enara
    Figueiro-Silva, Joana
    Luis Pedraz, Jose
    Igartua, Manoli
    Carro, Eva
    Maria Hernandez, Rosa
    MOLECULAR NEUROBIOLOGY, 2018, 55 (01) : 145 - 155
  • [5] Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson’s Disease
    Sara Hernando
    Enara Herran
    Joana Figueiro-Silva
    José Luis Pedraz
    Manoli Igartua
    Eva Carro
    Rosa Maria Hernandez
    Molecular Neurobiology, 2018, 55 : 145 - 155
  • [6] The Future of GDNF in Parkinson's Disease
    Manfredsson, Fredric P.
    Polinski, Nicole K.
    Subramanian, Thyagarajan
    Boulis, Nicholas
    Wakeman, Dustin R.
    Mandel, Ronald J.
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [7] GDNF in treatment of Parkinson's disease
    Penn, RD
    Dalvi, A
    Slevin, J
    Young, B
    Gash, D
    Gerhardt, G
    Hutchinson, M
    LANCET NEUROLOGY, 2006, 5 (03): : 202 - 203
  • [8] Development of a new preclinical model of Parkinson’s disease
    Alexandra Le Bras
    Lab Animal, 2020, 49 : 219 - 219
  • [9] Development of a new preclinical model of Parkinson's disease
    Le Bras, Alexandra
    LAB ANIMAL, 2020, 49 (08) : 219 - 219
  • [10] Preclinical development of gene therapy for Parkinson's disease
    Porras, Gregory
    Bezard, Erwan
    EXPERIMENTAL NEUROLOGY, 2008, 209 (01) : 72 - 81
12345